Healthcare Analytics, Population Health Management, Healthcare Big Data

Precision Medicine

Clinical Decision Support from Dana-Farber Powers Cancer Care

June 22, 2018 - Experts at Dana-Farber Cancer Institute are partnering with Royal Philips to provide improved clinical decision support for cancer care. The incredibly complex nature of cancer, coupled with its many available treatment options, has long made this set of diseases a major point of focus for healthcare stakeholders seeking to improve clinical decision support and develop more personalized care...

More Articles

FDA: Drug Development Transparency Key for Precision Medicine

by Jessica Kent

New guidance from the FDA urges drug development stakeholders to be transparent with their data as a way to maintain high quality and foster patient-centered precision medicine.   Innovative, personalized treatments are being developed at...

WVU Genetic Test to Improve Lung Cancer Treatment

by Jessica Kent

Researchers at the West Virginia University (WVU) Cancer Institute are developing a genetic test that will improve treatment for patients with lung cancer and help physicians determine which patients will benefit from chemotherapy and immunotherapy....

NIH Precision Medicine Clinical Trial Releases New Findings

by Jessica Kent

The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has released results from several sub-studies that could bring targeted treatments to patients with...

Broader Availability of Genetic Testing a Boon for Precision Care

by Jennifer Bresnick

Precision medicine is quickly moving out of the realm of science fiction and into the everyday routines of oncologists, neurologists, and other providers treating patients who may have had little hope just a few short years ago. While the cures...

NIH Recommends Precision Medicine Approach to Treat Alzheimer’s

by Jessica Kent

Precision medicine, big data analytics, and stakeholder collaboration could improve treatment and prevention of Alzheimer’s disease and related dementias, according to recommendations from the National Institutes of Health (NIH). The recommendations...

Harvard, Cancer Orgs Unite to Accelerate Precision Medicine Research

by Jessica Kent

The Harvard Business School Kraft Precision Medicine Accelerator has announced that five leading cancer organizations will come together to share best practices, engage patients, and create synergies to advance precision medicine across cancers....

Geisinger Adds Genomic Sequencing to Routine Clinical Care

by Jessica Kent

Geisinger Health System has announced that it will soon include genomic sequencing in routine clinical care in an effort to advance precision medicine and improve patient outcomes. “Understanding the genome warning signals of every patient...

NIH Opens Up “All of Us” to Research Participants Nationwide

by Jessica Kent

The National Institutes of Health’s (NIH) All of Us precision medicine research program is now open to all individuals 18 and older nationwide, allowing participants across the country to contribute their data to a research resource that...

LG Health, Aspire Launch $300M AI, IoT, Precision Medicine Fund

by Jessica Kent

Aspire Universal has partnered with Penn Medicine Lancaster General Health (LG Health) to introduce the Aspire Ventures Precision Medicine Fund (AVP), a $300 million initiative that will accelerate personalized device and medical practice innovation...

Machine Learning Can Quiet “Building Crescendo” of EHR Dissatisfaction

by Jennifer Bresnick

The notion that electronic health records are difficult to work with and cumbersome to use has become a worryingly common theme across the healthcare industry.  Providers working in organizations of all sizes, settings, and specialties have...

Intermountain Launches Prospective Precision Medicine Study

by Jennifer Bresnick

Intermountain Healthcare is launching a new precision medicine project that will allow researchers to take a prospective view on the potential of genomic data. The PRECISE study allows for the collection of fresh-frozen tissue and blood specimens...

Henry Ford to Apply Data Analytics to Pancreatic Cancer with $20M Gift

by Jennifer Bresnick

An anonymous $20 million donation to Henry Ford Health System will help the health system leverage big data analytics for the early detection and better treatment of pancreatic cancer. The Henry Ford Pancreatic Cancer Center will focus on fostering...

AHA Precision Medicine Platform Offers Up Data for Machine Learning

by Jessica Kent

Precision medicine driven by machine learning offers the promise of tailored, individualized treatment, improved patient outcomes, and better overall population health. However, the promise of precision medicine is often overshadowed by the data...

Former Telemedicine Leader Founds Artificial Intelligence Group

by Jennifer Bresnick

Jonathan Linkous, founder and former CEO of the American Telemedicine Association (ATA), is taking on a new role as the leader of a trade group dedicated to exploring the potential of artificial intelligence in healthcare. The Partnership for...

NIH Offers Funds for “All of Us” Genomic Data Collection Centers

by Jessica Kent

The National Institutes of Health (NIH) intends to issue a funding announcement to request applications for large-scale Genome Centers to generate genomic data as part of its All of Us precision medicine research program. All of Us is currently...

Healthy Nevada Study Combines Genomics, Population Health

by Jennifer Bresnick

A unique population health study in Nevada is combining genomic information from thousands of citizens with socioeconomic, environmental, and clinical data to develop insights into how lifestyle interacts with genetics. The Healthy Nevada Project,...

Payers Starting to Tie Precision Medicine to Value-Based Care

by Jennifer Bresnick

Precision medicine has started to offer important answers to patients with diseases that have a genetic component, but covering the costs of cutting-edge testing and emerging therapies can be a challenge. Payers are often hesitant to commit to...

Roche Buys Flatiron Cancer Analytics, EHR Tools for $1.9B

by Jennifer Bresnick

Swiss pharmaceutical giant Roche will purchase Flatiron Health’s cancer analytics assets for $1.9 billion in an effort to enhance the drug development process and further the progress of precision medicine. Flatiron Health, backed by Google...

Big Data Analytics Fuels Penn State Precision Health Research

by Jessica Kent

Penn State researchers recently announced their plan to create a Digital Collaboratory for Precision Health Research that will leverage big data analytics to boost individualized care. Project collaborators hope to develop a secure health IT...


Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy

no, thanks